Archives
-
FPR2/ALX Restricts Autoimmune Astrocytopathy
2026-09-03
The reference study identifies FPR2/ALX stimulation with Quin-C1 as a way to reduce antibody- and complement-driven astrocyte injury in a mouse model of autoimmune astrocytopathy. Its depletion and pathway-inhibition experiments connect protection to microglia, natural killer cells, and SYK-AKT signaling, offering a mechanistic framework for studying neuroinflammation in NMOSD-related pathology.
-
Silybin A and the Adipose–Liver Axis
2026-09-02
Silybin A offers a chemically defined pharmacology arm for studying oxidative stress, inflammation, and liver–adipose communication. This article integrates its assay use with targeted Fabp4 CRISPRi to improve experimental interpretation in metabolic disease research.
-
VX-765 for Caspase-1 Inflammation Research
2026-09-02
VX-765 enables selective interrogation of caspase-1-dependent cytokine release, pyroptosis, and barrier injury without treating every inflammatory signal as equivalent. This workflow-focused guide connects biochemical assays with macrophage, blood-brain barrier, rheumatoid arthritis, and HIV-associated models while emphasizing controls, dosing logic, and troubleshooting.
-
LGK-974: A Context-Aware PORCN Inhibitor
2026-09-01
LGK-974 is a potent PORCN inhibitor for separating Wnt ligand supply from downstream pathway activity. This guide connects developmental Wnt gradients with cancer assay design, emphasizing timing, spatial readouts, and dependency-aware interpretation.
-
Diethylmaleate: Turning Redox Stress Into Insight
2026-09-01
Diethylmaleate is more than a glutathione-depleting compound: it is a practical perturbation tool for testing how redox buffering shapes stress adaptation, apoptosis, and resistance. This thought-leadership article connects insecticide-resistance evidence with translational experimental design, showing how researchers can use controlled GSH depletion to distinguish GST-dependent defense from broader oxidative injury while avoiding overinterpretation across species and model systems.
-
BENPs Strengthen FLASH-RT Antitumor Effects
2026-08-31
Xu et al. developed functionalized self-assembled EGCG nanoparticles, termed BENPs, as a radiosensitizing strategy for FLASH-RT. Their findings indicate that BENPs amplify radiation-associated ROS and DNA damage while promoting tumor-cell death and broader antitumor immune activation, although further work is needed to establish formulation, dose, and clinical transferability.
-
Direct Mouse Genotyping Kit Plus for Lineage Studies
2026-08-31
The Direct Mouse Genotyping Kit Plus supports rapid, purification-free PCR for mouse model verification. This article presents a provenance-centered strategy for connecting allele identity with lineage-tracing and macrophage biology while clarifying assay limits and validation decisions.
-
Difloxacin HCl for Reliable Cell Assays
2026-08-30
Difloxacin HCl (SKU A8411) can help researchers design better-controlled antimicrobial susceptibility, multidrug-resistance, and cell-based viability workflows. This scenario-driven guide explains formulation limits, assay controls, interpretation boundaries, and practical product-selection criteria.
-
SM-164 Workflows for IAP-Driven Apoptosis
2026-08-29
SM-164 is a bivalent Smac mimetic for dissecting cIAP-1/2 degradation, XIAP antagonism, and TNFα-dependent apoptosis in tumor models. This practical guide translates its mechanism into reproducible cell-based assays, orthogonal caspase readouts, and troubleshooting decisions for cancer research.
-
O-GlcNAcylation Links Wnt to Bone Formation
2026-08-28
The reference study identifies protein O-GlcNAcylation as a functional metabolic relay connecting Wnt3a stimulation with aerobic glycolysis, osteoblastogenesis, and fracture healing. Its mechanistic focus on GFAT1-dependent signaling and O-GlcNAcylated PDK1 provides a framework for studying how Wnt signaling modulation is coupled to glucose metabolism in bone.
-
PNU 74654 for Wnt Signaling Studies
2026-08-28
PNU 74654 provides a DMSO-soluble, reversible way to interrogate Wnt/β-catenin signaling in cancer, stem cell, and progenitor-cell assays. This workflow emphasizes pathway engagement, dose-matched controls, and careful distinction between direct Wnt inhibition and the GSK3 blockade used in muscle FAP research.
-
NSP15 Screening: Thymopentin and Oleuropein
2026-08-27
This 2021 study used structure-based virtual screening and molecular dynamics simulations to identify thymopentin and oleuropein as high-ranking natural-product binders of the SARS-CoV-2 endoribonuclease NSP15. The work provides a computational prioritization framework for targeting viral immune evasion, while its findings remain preliminary until confirmed by biochemical, cellular, and infection-model experiments.
-
CHIR-99021 and Genome-Folding-Aware Assays
2026-08-27
CHIR-99021 (CT99021) is more than a Wnt-pathway tool: it can help investigators design stem-cell assays that distinguish signaling effects from genome-architecture effects. This guide connects selective GSK-3 inhibition with new insights into cohesin-dependent loop extrusion and practical experimental controls.
-
Indazole/Indole Glucagon Receptor Antagonists
2026-08-26
Lin and co-workers reported a new indazole- and indole-based series of glucagon receptor antagonists derived from the pyrazole lead MK-0893. The study combined focused structure–activity relationship studies with rat pharmacokinetics and acute efficacy testing in glucagon receptor humanized mice, identifying GRA 16d as an orally active compound in glucose challenge models.
-
BQCA Workflows for M1 Receptor Signaling
2026-08-26
BQCA enables controlled potentiation of M1 muscarinic receptor signaling rather than relying on maximal orthosteric stimulation. This guide translates its selectivity, BRET-compatible behavior, and brain-activity evidence into practical workflows for acetylcholine receptor signaling, cognitive function modulation, and Alzheimer’s disease research.